Page 231 - Read Online

inflammatory cytokines as key modulators of neurogenesis. Trends 2012;14:527‑36.
Neurosci 2015;38:145‑57. 91. Barbosa IG, Huguet RB, Mendonca VA, Sousa LP, Neves FS,
72. Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between Bauer ME, Teixeira AL. Increased plasma levels of soluble TNF
pro‑inflammatory and anti‑inflammatory cytokines in bipolar receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin
disorder. J Affect Disord 2007;104:91‑5. Neurosci 2011;261:139‑43.
73. Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard BE, 92. Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P,
Steinbusch HW. T‑helper types 1, 2, and 3 cytokine interactions in Andreassen OA. Affective symptoms are associated with markers
symptomatic manic patients. Psychiatry Res 2004;129:267‑72. of inflammation and immune activation in bipolar disorders but not
74. Soderlund J, Olsson SK, Samuelsson M, Walther‑Jallow L, in schizophrenia. J Psychiatr Res 2011;45:1608‑16.
Johansson C, Erhardt S, Landen M, Engberg G. Elevation of 93. Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO,
cerebrospinal fluid interleukin‑1β in bipolar disorder. J Psychiatry Agartz I, Aukrust P, Andreassen OA. Interleukin 1 receptor antagonist
Neurosci 2011;36:114‑8. and soluble tumor necrosis factor receptor 1 are associated with
75. Monfrim X, Gazal M, De Leon PB, Quevedo L, Souza LD, Jansen K, general severity and psychotic symptoms in schizophrenia and
Oses JP, Pinheiro RT, Silva RA, Lara DR, Ghisleni G, Spessato B, bipolar disorder. Schizophr Res 2013;145:36‑42.
Kaster MP. Immune dysfunction in bipolar disorder and suicide risk: 94. Park KM, Bowers WJ. Tumor necrosis factor‑alpha mediated
is there an association between peripheral corticotropin‑releasing signaling in neuronal homeostasis and dysfunction. Cell Signal
hormone and interleukin‑1beta? Bipolar Disord 2014;16:741‑7. 2010;22:977‑83.
76. Sani G, Tondo L, Koukopoulos A, Reginaldi D, Kotzalidis GD, 95. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial
Koukopoulos AE, Manfredi G, Mazzarini L, Pacchiarotti I, TNF‑alpha. Nature 2006;440:1054‑9.
Simonetti A, Ambrosi E, Angeletti G, Girardi P, Tatarelli R. Suicide 96. Brietzke E, Kapczinski F. TNF‑alpha as a molecular target in
in a large population of former psychiatric inpatients. Psychiatry bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry
Clin Neurosci 2011;65:286‑95. 2008;32:1355‑61.
77. Shim IH, Woo YS, Bahk WM. Prevalence rates and clinical 97. Doganavsargil‑Baysal O, Cinemre B, Aksoy UM, Akbas H, Metin O,
implications of bipolar disorder “with mixed features” as defined Fettahoglu C, Gokmen Z, Davran F. Levels of TNF‑alpha, soluble
by DSM‑5. J Affect Disord 2015;173:120‑5. TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
78. Tsai SY, Chung KH, Wu JY, Kuo CJ, Lee HC, Huang SH. Hum Psychopharmacol 2013;28:160‑7.
Inflammatory markers and their relationships with leptin and insulin 98. D’Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into
from acute mania to full remission in bipolar disorder. J Affect Disord the brain in response to tumor necrosis factoralpha signaling during
2012;136:110‑6. peripheral organ inflammation. J Neurosci 2009;29:2089‑102.
79. Brietzke E, Stertz L, Fernandes BS, Kauer‑Sant’anna M, 99. Saijo K, Glass CK. Microglial cell origin and phenotypes in health
Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F. and disease. Nat Rev Immunol 2011;11:775‑87.
Comparison of cytokine levels in depressed, manic and euthymic 100. Tsai SY, Chung KH, Huang SH, Chen PH, Lee HC, Kuo CJ.
patients with bipolar disorder. J Affect Disord 2009;116:214‑7. Persistent inflammation and its relationship to leptin and insulin in
80. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin‑2 phases of bipolar disorder from acute depression to full remission.
and interleukin‑6 in schizophrenia and mania: effects of neuroleptics Bipolar Disord 2014;16:800‑8.
and mood stabilizers. J Psychiatr Res 1995;29:141‑52. 101. Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE,
81. O’Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in Goncalves CA, Kapczinski F. Investigation of serum high‑sensitive
bipolar affective disorder: focus on acutely ill patients. J Affect Disord C‑reactive protein levels across all mood states in bipolar disorder.
2006;90:263‑7. Eur Arch Psychiatry Clin Neurosci 2008;258:300‑4.
82. Tsai SY, Yang YY, Kuo CJ, Chen CC, Leu SJ. Effects of symptomatic 102. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R.
severity on elevation of plasma soluble interleukin‑2 receptor in Elevated serum levels of C‑reactive protein are associated with
bipolar mania. J Affect Disord 2001;64:185‑93. mania symptoms in outpatients with bipolar disorder. Prog
83. Tsai SY, Lee CH, Huang SH, Chung KH, Chen PH. Soluble Neuropsychopharmacol Biol Psychiatry 2007;31:952‑5.
interleukin‑6 receptor level reflecting the illness activity in bipolar 103. Lee SY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS,
disorder. Aust N Z J Psychiatry 2014;48:382‑3. Wang YS, Wang LJ, Lee IH, Wang TY, Yeh TL, Yang YK, Hong JS,
84. Munkholm K, Vinberg M, Vedel Kessing L. Cytokines in bipolar Lu RB. Inflammation’s association with metabolic profiles before and
disorder: a systematic review and meta‑analysis. J Affect Disord after a twelve‑week clinical trial in drug‑naive patients with bipolar
2013;144:16‑27. II disorder. PLoS One 2013;8:e66847.
85. Kauer‑Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, 104. Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M.
Lam RW, Young LT, Yatham LN. Brain‑derived neurotrophic factor Serological observations in patients suffering from acute manic
and inflammatory markers in patients with early‑ vs. late‑stage episodes. Hum Psychopharmacol 2002;17:175‑9.
bipolar disorder. Int J Neuropsychopharmacol 2009;12:447‑58. 105. Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ.
86. Guloksuz S, Cetin EA, Cetin T, Deniz G, Oral ET, Nutt DJ. Cytokine Immunologic variables in acute mania of bipolar disorder.
levels in euthymic bipolar patients. J Affect Disord 2010;126:458‑62. J Neuroimmunol 2004;150:116‑22.
87. Jia D, Gao GD, Liu Y, He SM, Zhang XN, Zhang YF, Zhao MG. 106. Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK, Leu SJ.
TNF‑alpha involves in altered prefrontal synaptic transmission in Activation of indices of cell‑mediated immunity in bipolar mania.
mice with persistent inflammatory pain. Neurosci Lett 2007;415:1‑5. Biol Psychiatry 1999;45:989‑94.
88. Barzman D, Eliassen J, McNamara R, Abonia P, Mossman D, 107. Barbosa IG, Rocha NP, Assis F, Vieira EL, Soares JC, Bauer ME,
Durling M, Adler C, DelBello M, Lin PI. Correlations of inflammatory Teixeira AL. Monocyte and lymphocyte activation in bipolar
gene pathways, corticolimbic functional activities, and aggression disorder: a new piece in the puzzle of immune dysfunction in mood
in pediatric bipolar disorder: a preliminary study. Psychiatry Res disorders. Int J Neuropsychopharmacol 2014;18:pii: pyu021. doi:
2014;224:107‑11. 10.1093/ijnp/pyu021.
89. Barbosa IG, Rocha NP, Huguet RB, Ferreira RA, Salgado JV, 108. Haarman BC, Riemersma‑Van der Lek RF, Burger H, Netkova M,
Carvalho LA, Pariante CM, Teixeira AL. Executive dysfunction in Drexhage RC, Bootsman F, Mesman E, Hillegers MH, Spijker AT,
euthymic bipolar disorder patients and its association with plasma Hoencamp E, Drexhage HA, Nolen WA. Relationship between
biomarkers. J Affect Disord 2012;137:151‑5. clinical features and inflammation‑related monocyte gene
90. Ryan KA, Vederman AC, McFadden EM, Weldon AL, Kamali M, expression in bipolar disorder ‑ Towards a better understanding of
Langenecker SA, McInnis MG. Differential executive functioning psychoimmunological interactions. Bipolar Disord 2014;16:137‑50.
performance by phase of bipolar disorder. Bipolar Disord 109. Cassidy F, Wilson WH, Carroll BJ. Leukocytosis and hypoalbuminemia

Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015 223